GALWAY, IRELAND--February 23, 2021--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--AstraZeneca is planning to build a new COVID-19 vaccine plant in Germany with IDT Biologika to boost vaccine output and overcome problems with initial European supplies. Within this article: Details new plant plans, partners,
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×For More Info!
